within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H02A_CorticosteroidsForSystemicUsePlain.H02AA02_Fludrocortisone;

model Fludrocortisone
  extends Pharmacolibrary.Drugs.ATC.H.H02AA02
  // parameters inherited from base class, duplicate, uncomment and change if necesarry
  /*
  
    weight         = 70,
    F              = 0.95,
    Cl             = 8.333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 0.2 / 1000000,
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600  
  */
  ;

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Fludrocortisone</td></tr><tr><td>ATC code:</td><td>H02AA02</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>0.2</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.5</td><td>L</td></tr>
    <tr><td>clearance:</td><td>30</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Fludrocortisone is a synthetic corticosteroid with potent mineralocorticoid properties, primarily used in the treatment of adrenocortical insufficiency (Addison's disease) and orthostatic hypotension. It is approved and in clinical use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following single oral dose.</p><h4>References</h4><ol><li><p>Polito, A, et al., &amp; Alvarez, JC (2016). Pharmacokinetics of oral fludrocortisone in septic shock. <i>British journal of clinical pharmacology</i> 82(6) 1509–1516. DOI:<a href=\"https://doi.org/10.1111/bcp.13065\">10.1111/bcp.13065</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27416887/\">https://pubmed.ncbi.nlm.nih.gov/27416887</a></p></li><li><p>Hamitouche, N, et al., &amp; Laviolle, B (2017). Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers. <i>The AAPS journal</i> 19(3) 727–735. DOI:<a href=\"https://doi.org/10.1208/s12248-016-0041-9\">10.1208/s12248-016-0041-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28083797/\">https://pubmed.ncbi.nlm.nih.gov/28083797</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Fludrocortisone;
